New Risk • May 21
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Australian stocks, typically moving 21% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (21% average weekly change). Revenue is less than US$1m (AU$406k revenue, or US$289k). Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (AU$948k net loss in 2 years). Market cap is less than US$100m (AU$50.5m market cap, or US$36.0m). Anuncio • Feb 18
AnteoTech Limited to Report First Half, 2026 Results on Feb 25, 2026 AnteoTech Limited announced that they will report first half, 2026 results on Feb 25, 2026 Anuncio • Jan 27
AnteoTech Limited has completed a Follow-on Equity Offering in the amount of AUD 3.80835 million. AnteoTech Limited has completed a Follow-on Equity Offering in the amount of AUD 3.80835 million.
Security Name: Ordinary Share
Security Type: Common Stock
Securities Offered: 245,699,993
Price\Range: AUD 0.0155
Discount Per Security: AUD 0.00093
Security Features: Attached Options
Transaction Features: Subsequent Direct Listing New Risk • Jan 08
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 14% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Revenue is less than US$1m (AU$969k revenue, or US$649k). Minor Risks Less than 1 year of cash runway based on current free cash flow (-AU$6.0m). Currently unprofitable and not forecast to become profitable over next 3 years (AU$500k net loss in 3 years). Share price has been volatile over the past 3 months (14% average weekly change). Market cap is less than US$100m (AU$60.0m market cap, or US$40.2m). Anuncio • Oct 03
AnteoTech Limited, Annual General Meeting, Nov 26, 2025 AnteoTech Limited, Annual General Meeting, Nov 26, 2025. Reported Earnings • Aug 28
Full year 2025 earnings released: AU$0.003 loss per share (vs AU$0.004 loss in FY 2024) Full year 2025 results: AU$0.003 loss per share (improved from AU$0.004 loss in FY 2024). Revenue: AU$3.46m (up AU$3.00m from FY 2024). Net loss: AU$6.76m (loss narrowed 24% from FY 2024). Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has fallen by 26% per year, which means it is significantly lagging earnings. Anuncio • Aug 14
AnteoTech Limited to Report Fiscal Year 2025 Results on Aug 28, 2025 AnteoTech Limited announced that they will report fiscal year 2025 results on Aug 28, 2025 Anuncio • Apr 24
AnteoTech Limited to Report Q3, 2025 Results on Apr 30, 2025 AnteoTech Limited announced that they will report Q3, 2025 results on Apr 30, 2025 Anuncio • Feb 12
AnteoTech Limited to Report First Half, 2025 Results on Feb 26, 2025 AnteoTech Limited announced that they will report first half, 2025 results on Feb 26, 2025 Anuncio • Nov 20
AnteoTech Limited has completed a Follow-on Equity Offering in the amount of AUD 3.5 million. AnteoTech Limited has completed a Follow-on Equity Offering in the amount of AUD 3.5 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 175,000,000
Price\Range: AUD 0.02
Discount Per Security: AUD 0.0012
Transaction Features: Subsequent Direct Listing Anuncio • Nov 14
AnteoTech Limited has filed a Follow-on Equity Offering in the amount of AUD 4.97954 million. AnteoTech Limited has filed a Follow-on Equity Offering in the amount of AUD 4.97954 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 248,977,000
Price\Range: AUD 0.02
Discount Per Security: AUD 0.0012
Transaction Features: Rights Offering Anuncio • Oct 02
AnteoTech Limited, Annual General Meeting, Nov 26, 2024 AnteoTech Limited, Annual General Meeting, Nov 26, 2024. New Risk • Aug 28
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$7.6m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$7.6m free cash flow). Earnings have declined by 28% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (14% increase in shares outstanding). Revenue is less than US$5m (AU$4.3m revenue, or US$2.9m). Market cap is less than US$100m (AU$51.8m market cap, or US$35.2m). Reported Earnings • Aug 28
Full year 2024 earnings released: AU$0.004 loss per share (vs AU$0.006 loss in FY 2023) Full year 2024 results: AU$0.004 loss per share (improved from AU$0.006 loss in FY 2023). Net loss: AU$8.88m (loss narrowed 30% from FY 2023). Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has fallen by 49% per year, which means it is performing significantly worse than earnings. Anuncio • Aug 22
AnteoTech Limited to Report Fiscal Year 2024 Results on Aug 28, 2024 AnteoTech Limited announced that they will report fiscal year 2024 results on Aug 28, 2024 Anuncio • Apr 28
AnteoTech Limited, Annual General Meeting, May 28, 2024 AnteoTech Limited, Annual General Meeting, May 28, 2024, at 11:30 E. Australia Standard Time. Location: the offices of Sparke Helmore Lawyers, Level 23, 240 Queen Street Brisbane Queensland Australia Agenda: To consider ratification of prior issue of placement shares; to consider ratification of prior issue of SPP shares; to consider approval of issue of new options; to consider approval of issue of placement shares and new options to directors; and to consider other matters. Anuncio • Apr 10
AnteoTech Limited has completed a Follow-on Equity Offering in the amount of AUD 5.4 million. AnteoTech Limited has completed a Follow-on Equity Offering in the amount of AUD 5.4 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 216,000,000
Price\Range: AUD 0.025
Discount Per Security: AUD 0.0015
Security Features: Attached Options
Transaction Features: Subsequent Direct Listing Anuncio • Apr 09
AnteoTech Limited has filed a Follow-on Equity Offering in the amount of AUD 2.5 million. AnteoTech Limited has filed a Follow-on Equity Offering in the amount of AUD 2.5 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 100,000,000
Price\Range: AUD 0.025
Discount Per Security: AUD 0.0015
Security Features: Attached Options Anuncio • Feb 23
AnteoTech Limited to Report First Half, 2024 Results on Feb 28, 2024 AnteoTech Limited announced that they will report first half, 2024 results on Feb 28, 2024 New Risk • Nov 30
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 12% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$8.8m free cash flow). Earnings have declined by 36% per year over the past 5 years. Revenue is less than US$1m (AU$366k revenue, or US$242k). Minor Risks Share price has been volatile over the past 3 months (12% average weekly change). Shareholders have been diluted in the past year (10% increase in shares outstanding). Market cap is less than US$100m (AU$74.7m market cap, or US$49.4m). Anuncio • Sep 27
AnteoTech Limited, Annual General Meeting, Nov 14, 2023 AnteoTech Limited, Annual General Meeting, Nov 14, 2023. Reported Earnings • Aug 30
Full year 2023 earnings released: AU$0.006 loss per share (vs AU$0.005 loss in FY 2022) Full year 2023 results: AU$0.006 loss per share (further deteriorated from AU$0.005 loss in FY 2022). Net loss: AU$12.7m (loss widened 18% from FY 2022). Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings. New Risk • Aug 24
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$10m free cash flow). Earnings have declined by 32% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Share price has been volatile over the past 3 months (13% average weekly change). Shareholders have been diluted in the past year (9.4% increase in shares outstanding). Revenue is less than US$5m (AU$1.9m revenue, or US$1.3m). Market cap is less than US$100m (AU$60.9m market cap, or US$39.4m). Anuncio • Aug 21
AnteoTech Limited to Report Fiscal Year 2023 Results on Aug 30, 2023 AnteoTech Limited announced that they will report fiscal year 2023 results on Aug 30, 2023 Anuncio • Jun 27
AnteoTech Limited Announces Retirement of Christopher Parker from the Board of Directors AnteoTech Ltd. announced the retirement of Christopher Parker from the board of directors on 27 June 2023. Mr. Parker was appointed to the company board on 23 April 2019 having previously served as Chief Executive Officer since first joining the company in April 2018. In particular, he held the position of Executive Director from March 2022 to September 2022 during a period of substantial change for the company. Reported Earnings • Feb 22
First half 2023 earnings released: AU$0.002 loss per share (vs AU$0.002 loss in 1H 2022) First half 2023 results: AU$0.002 loss per share (in line with 1H 2022). Net loss: AU$3.55m (loss narrowed 7.2% from 1H 2022). Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has increased by 25% per year, which means it is well ahead of earnings. Anuncio • Feb 15
AnteoTech Limited Appoints Tsui Min Lian as Chief Marketing Officer, Effective 15 March 2023 AnteoTech Limited announced the appointment of Ms. Tsui Min Lian to the newly created position of Chief Marketing Officer effective 15 March 2023. The appointment of Ms. Lian, initially on a contract basis, is part of the Company's increasing focus on becoming a marketing lead sales-driven business. Ms. Lian is an experienced sales and marketing leader with extensive local and international experience, having worked for Blue Chip companies, including General Electric, ResMed and Toll Group, where she has been responsible for driving growth and profitability within the business units. As a qualified pharmacist, Ms Lian has a proven track record in commercialisation, translating technology and ideas into new products and services, building strategic partnerships and commercial models within multiple industry sectors with a focus upon the delivery of profitable revenue growth. This experience will bring a new focus upon the Life Sciences and Clean Energy Technology businesses as the Company moves to accelerate the commercialisation of its products and services. Ms. Lian holds an MBA from the University of Adelaide, a Graduate Diploma in Marketing, and a BSc (Hons) Pharmacy from the UK. Recent Insider Transactions • Dec 18
Non-Executive Director recently sold AU$61k worth of stock On the 16th of December, Geoffrey Cumming sold around 1m shares on-market at roughly AU$0.061 per share. This transaction amounted to 4.0% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of AU$443k more than they bought in the last 12 months. Board Change • Nov 17
High number of new and inexperienced directors There are 9 new directors who have joined the board in the last 3 years. The company's board is composed of: 9 new directors. 1 experienced director. 1 highly experienced director. Non-Executive Director Geoff Cumming is the most experienced director on the board, commencing their role in 2009. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Reported Earnings • Aug 25
Full year 2022 earnings released: AU$0.005 loss per share (vs AU$0.003 loss in FY 2021) Full year 2022 results: AU$0.005 loss per share (down from AU$0.003 loss in FY 2021). Net loss: AU$10.7m (loss widened 72% from FY 2021). Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has increased by 69% per year, which means it is well ahead of earnings. Recent Insider Transactions • Jun 18
Non-Executive Director recently sold AU$106k worth of stock On the 14th of June, Geoffrey Cumming sold around 2m shares on-market at roughly AU$0.071 per share. In the last 3 months, they made an even bigger sale worth AU$220k. Insiders have been net sellers, collectively disposing of AU$461k more than they bought in the last 12 months. Recent Insider Transactions • May 06
Non-Executive Director recently sold AU$220k worth of stock On the 3rd of May, Geoffrey Cumming sold around 2m shares on-market at roughly AU$0.11 per share. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of AU$382k more than they bought in the last 12 months. Board Change • Apr 27
High number of new and inexperienced directors There are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 2 experienced directors. 1 highly experienced director. Non-Executive Director Geoff Cumming is the most experienced director on the board, commencing their role in 2009. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Recent Insider Transactions • Dec 27
Non-Executive Director recently sold AU$108k worth of stock On the 23rd of December, Geoffrey Cumming sold around 500k shares on-market at roughly AU$0.22 per share. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of AU$162k more than they bought in the last 12 months. Executive Departure • Dec 01
Company Secretary Duncan Cornish has left the company On the 30th of November, Duncan Cornish's tenure as Company Secretary ended after 2.8 years in the role. As of September 2021, Duncan still personally held 962.15k shares (AU$255k worth at the time). A total of 3 executives have left over the last 12 months. The current median tenure of the management team is 2.79 years. Board Change • Nov 01
High number of new and inexperienced directors There are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 1 experienced director. 1 highly experienced director. Non-Executive Director Geoff Cumming is the most experienced director on the board, commencing their role in 2009. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Board Change • Oct 02
High number of new and inexperienced directors There are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 1 experienced director. 1 highly experienced director. Non-Executive Director Geoff Cumming is the most experienced director on the board, commencing their role in 2009. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Recent Insider Transactions • Sep 22
Independent Non-Executive Director recently bought AU$59k worth of stock On the 17th of September, Glenda McLoughlin bought around 250k shares on-market at roughly AU$0.23 per share. This was the largest purchase by an insider in the last 3 months. Despite this recent purchase, insiders have collectively sold AU$183k more in shares than they bought in the last 12 months. Board Change • Sep 08
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Chairman Jack Hamilton was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Sep 02
Full year 2021 earnings released: AU$0.003 loss per share (vs AU$0.002 loss in FY 2020) Full year 2021 results: Net loss: AU$6.22m (loss widened 99% from FY 2020). Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has increased by 129% per year, which means it is well ahead of earnings. Executive Departure • Sep 01
Chief Financial Officer Gail Jukes has left the company On the 31st of August, Gail Jukes' tenure as Chief Financial Officer ended after less than a year in the role. We don't have any record of a personal shareholding under Gail's name. A total of 2 executives have left over the last 12 months. The current median tenure of the management team is 2.50 years. Recent Insider Transactions • Aug 03
Non-Executive Director recently sold AU$112k worth of stock On the 2nd of August, Geoffrey Cumming sold around 500k shares on-market at roughly AU$0.22 per share. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of AU$241k more than they bought in the last 12 months. Executive Departure • Apr 24
Independent Non-Executive Director has left the company On the 22nd of April, Matthew Sanderson's tenure as Independent Non-Executive Director ended after 3.5 years in the role. As of December 2020, Matthew personally held 10.28m shares (AU$1.1m worth at the time). Matthew is the only executive to leave the company over the last 12 months. Reported Earnings • Mar 04
First half 2021 earnings released: AU$0.001 loss per share (vs AU$0.001 loss in 1H 2020) The company reported a solid first half result with improved revenues and control over costs, although losses increased. First half 2021 results: Revenue: AU$1.75m (up 65% from 1H 2020). Net loss: AU$1.47m (loss widened 33% from 1H 2020). Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has increased by 141% per year, which means it is tracking significantly ahead of earnings growth. Is New 90 Day High Low • Feb 11
New 90-day high: AU$0.22 The company is up 147% from its price of AU$0.088 on 13 November 2020. The Australian market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Life Sciences industry, which is up 11% over the same period. 
